Artwork
iconShare
 
Manage episode 489211454 series 1401828
Content provided by OpenLP from Sapphire Partners. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by OpenLP from Sapphire Partners or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Origins hosts Nick Chirls, GP at Asylum Ventures and Beezer Clarkson, LP at Sapphire Partners and co-founder of OpenLP, unpack their conversation with Zach Weinberg, Co-Founder and CEO of Curie.Bio. They discuss the “innovation energy” that drives new breakthroughs and take a closer look at Sapphire’s approach to biotech investing.

Learn more about Sapphire Partners: ⁠https://sapphireventures.com/sapphire-partners⁠

Learn more about OpenLP: ⁠https://openlp.vc⁠

Learn more about Asylum Ventures: ⁠https://asylum.vc

Learn more about Curie.Bio: https://curie.bio

Subscribe to the OpenLP newsletter for a monthly roundup of the latest venture insights, including the newest Origins episodes, delivered straight to your inbox.

CHAPTERS:

0:00 - Welcome to Origins

1:28 -Building Something That Wouldn’t Exist Otherwise

4:27 - What’s Sapphire Doing in BioTech?

8:38 - The Market & BioTech

10:05 - "Vitamin O"

  continue reading

117 episodes